LEGAL PROCEEDINGS
−Removed: Legal proceedings in which we are involved are discussed in Note 13 (Legal Matters and Contingencies) of the Notes to Consolidated Financial Statements appearing in this Annual Report on Form 10-K.
+Added: Legal proceedings in which we are involved are discussed in Note 13 (Legal Matters and Contingencies) and Note 14 (Litigation Settlements) of the Notes to Consolidated Financial Statements appearing in this Annual Report on Form 10-K.
MINE SAFETY DISCLOSURES
3 unchanged sentences
Name Age Current Position with the Company
−Removed: Collis 62 Chairman, President, and Chief Executive Officer
+Added: Mauch 57 President and Chief Executive Officer
+Added: Collis 63 Executive Chairman of the Board
Silvana Battaglia 57 Executive Vice President and Chief Human Resources Officer
Campbell 50 Executive Vice President and Chief Legal Officer
−Removed: Clark 66 Executive Vice President and Chief Communications & Administration Officer
Cleary 61 Executive Vice President and Chief Financial Officer
−Removed: Donato 54 Executive Vice President and Chief Strategy Officer
−Removed: Mauch 56 Executive Vice President and Chief Operating Officer
Unless indicated to the contrary, the business experience summaries provided below for our executive officers describe positions held by the named individuals during the last five years.
−Removed: Collis has been President and Chief Executive Officer of the Company since July 2011 and Chairman since March 2016.
+Added: Mauch has been President and Chief Executive Officer of the Company and a member of the Board since October 2024.
+Added: Prior to that, he served as Executive Vice President and Chief Operating Officer from October 2022 to September 2024.
+Added: He served as Group President from February 2019 to September 2022.
+Added: He served as Group President, Pharmaceutical Distribution & Strategic Global Sourcing from June 2017 to February 2019.
+Added: He served as President, AmerisourceBergen Drug Corporation from February 2015 to June 2017.
+Added: Mauch served as Senior Vice President and Chief Operating Officer, AmerisourceBergen Drug Corporation from March 2014 to February 2015.
+Added: He was Senior Vice President, Operations, AmerisourceBergen Drug Corporation from April 2012 to March 2014.
+Added: He was Senior Vice President of Sales and Marketing, AmerisourceBergen Drug Corporation from April 2011 to April 2012.
+Added: He was Senior Vice President, Alternate Care Sales and Marketing, AmerisourceBergen Drug Corporation from May 2010 to April 2011.
+Added: Mauch has been employed by the Company or one of its predecessors for over 25 years.
+Added: Collis has been Executive Chairman of the Board since October 2024.
+Added: He served as President and Chief Executive Officer of the Company from July 2011 to September 2024 and as Chairman from March 2016 to September 2024.
From November 2010 to July 2011, he served as President and Chief Operating Officer.
10 unchanged sentences
Campbell has been employed by the Company for 14 years.
−Removed: Clark has been Executive Vice President since November 2014 and became Chief Communication & Administration Officer in June 2017.
−Removed: She served as Chief Marketing Officer from November 2014 to June 2017.
−Removed: Clark was named Senior Vice President and Chief Marketing Officer in June 2011.
−Removed: She previously served as Senior Vice President of Marketing and Business Development for AmerisourceBergen Specialty Group from January 2007 to June 2011.
−Removed: Prior to joining the Company, she worked in executive leadership roles at Premier Inc.
−Removed: and HealthSouth, including Senior Vice President of Marketing and Alliance Relations, Group Vice President of Relationship Management, and Senior Vice President of Managed Care and National Contracting.
Cleary has been Executive Vice President since March 2015 and became Chief Financial Officer in November 2018.
4 unchanged sentences
Cleary has been employed by the Company or one of its predecessors for over 25 years.
−Removed: Donato has been Executive Vice President and Chief Strategy Officer since July 2019.
−Removed: Prior to joining the Company, she held various leadership roles at Bayer from May 2009 to May 2019, including Vice President of Strategy, Pharmaceuticals Division, Vice President of Strategy, Bayer Healthcare US, and Vice President & General Manager of Neurology & Hematology.
−Removed: She also worked for McKinsey & Company where she was a Partner in the Healthcare Practice.
−Removed: Mauch has been Executive Vice President since February 2015 and became Chief Operating Officer in October 2022.
−Removed: He served as Group President from February 2019 to September 2022.
−Removed: He served as Group President, Pharmaceutical Distribution & Strategic Global Sourcing from June 2017 to February 2019.
−Removed: He served as President, AmerisourceBergen Drug Corporation from February 2015 to June 2017.
−Removed: Mauch served as Senior Vice President Chief Operating Officer, AmerisourceBergen Drug Corporation from March 2014 to February 2015.
−Removed: He was Senior Vice President, Operations, AmerisourceBergen Drug Corporation from April 2012 to March 2014.
−Removed: He was Senior Vice President of Sales and Marketing, AmerisourceBergen Drug Corporation from April 2011 to April 2012.
−Removed: He was Senior Vice President, Alternate Care Sales and
−Removed: Marketing, AmerisourceBergen Drug Corporation from May 2010 to April 2011.
−Removed: Mauch has been employed by the Company or one of its predecessors for over 25 years.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.